Riskpilot← Back to searchSign inGet full accessHelsingborg Royal Clinic AB
ABActiveOrg 5591632210Gasverksgatan 33 ADental practice care activities · NACE 8623Est. 201814 employees
Revenue 2025
SEK 19,5M
+16% vs 2024
EBITDA margin
5.3%
-34% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
SEK 644K
-42% vs 2024
| Revenue | SEK 19,5M | +16% |
| EBITDA | SEK 1M | -34% |
| Net profit | SEK 644K | -42% |
| Total assets | SEK 5,6M | +7% |
| Equity | SEK 3,8M | +21% |
| Employees | 14 | — |
Legal name
Helsingborg Royal Clinic AB
Org number
5591632210
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
21 juni 2018
Share capital
SEK 50 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Tandläkarverksamhet. Tandhygienistverksamhet. Skönhetsvård. Konsultverksamhet avseende utbildning.
Address
Gasverksgatan 33 A
Email
info@royalclinic.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 | 4 313 | 13 505 | 16 847 | 19 536 |
| Staff expenses | — | — | −6 179 | — | — |
| EBITDA | −505 | 2 054 | 1 082 | 1 575 | 1 045 |
| Depreciation & amort. | −2 | −30 | −99 | −110 | −127 |
| EBIT | −507 | 2 024 | 983 | 1 465 | 918 |
| Net financials | — | −1 | −1 | −1 | −2 |
| Profit before tax | −507 | 2 024 | 981 | 1 464 | 916 |
| Tax | −0 | −314 | −214 | −346 | −272 |
| Net profit | −507 | 1 710 | 767 | 1 118 | 644 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 410 | 2 461 | 3 249 | 5 240 | 5 599 |
| Equity | −469 | 1 241 | 2 008 | 3 126 | 3 770 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 879 | 1 220 | 1 241 | 2 114 | 1 828 |
| Total debt | 879 | 1 220 | 1 241 | 2 114 | 1 828 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20212025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20212025
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
20212025
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20212025
Asset turnover
3.49×
This company
1.12×
Market median
+212% vs market
20212025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2020 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2020 – 2025 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Helsingborg Royal Clinic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Anders Gyllenberg | Audit | 0 companies |
| Raed Al-Khafaji | Board of Directors | 0 companies |
| Doaa Alsholi | Deputy Board Member | 0 companies |
| Hiba Musa Abed | Deputy Board Member | 0 companies |
| Nooralhuda Al-Shiwili | Board of Directors | 0 companies |
| Hiba Musa Abed | Board of Directors | 0 companies |
| Ali Musa Abed | Board of Directors | 0 companies |
| Omar Najjar | Chairman | 0 companies |